ZW Data Action Technologies Inc. (CNET): Nasdaq/NYSE listing notice — ZW Data Action Technologies gets Nasdaq extension to cure bid price deficiency until Oct 28, 2024

ZW Data Action Technologies Inc.

Received second notice granting additional 180-day compliance period through October 28, 2024.
Must maintain closing bid price of $1.00+ for 10 consecutive business days to regain compliance.
Company intends to cure deficiency via reverse stock split if necessary.
Failure to comply by deadline will result in delisting notice; possible appeal to Hearings Panel.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

ZW Data Action Technologies Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: extension granted
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

May 1, 2024, the Company received another notice (the “Second Notice”) from Nasdaq indicating that, while the Company has not regained compliance with the Bid Price Requirement, Nasdaq has determined that the Company is eligible for an additional 180-day period, or until October 28, 2024, to regain compliance. According to the Second Notice from Nasdaq, the Staff’s determination was based on (i) the Company meeting the continued listing requirement for market value of its publicly held shares and all other Nasdaq initial listing standards, with the exception of the minimum bid price requiremen

View on SEC.gov

6 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

ZW Data Action Technologies Inc. filing history →

Source: SEC EDGAR

accession 0001171843-24-002485

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.